Urology
 |
|
9 june 2019 10:00:59 |
| Automated Bone Scan Index as an Imaging Biomarker to Predict Overall Survival in the Zometa European Study/SPCG11 (European Urology Oncology) |
|
Tweet The automated Bone Scan Index (aBSI) as an objective imaging biomarker-predicted outcome in prostate cancer patients in the Zometa European Study/SPCG11 study. A change in aBSI from baseline to 48-mo follow-up represents a valuable tool for prognostication and monitoring of patients with bone metastases. |
| 102 viewsCategory: Oncology, Urology |
 Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel (European Urology Oncology)ETS Rearrangements, Neuroendocrine Modulators, and Androgen Resistance: What Can the Microenvironment Reveal in Prostate Cancer? (European Urology Oncology) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page